DatasetName,RIPOR1_S(167) RIPOR1_S(22) RIPOR1_S(3) RIPOR1_S(310) RIPOR1_S(326) RIPOR1_S(342) RIPOR1_S(347) RIPOR1_S(350) RIPOR1_S(351) RIPOR1_S(367) RIPOR1_S(373) RIPOR1_S(401) RIPOR1_S(45) RIPOR1_S(7) RIPOR1_S(727) RIPOR1_T(168) RIPOR1_T(351) RIPOR1_T(371) RIPOR1_T(421) RIPOR1_Y(360),RIPOR1_S(17) RIPOR1_S(171) RIPOR1_S(187) RIPOR1_S(305) RIPOR1_S(330) RIPOR1_S(344) RIPOR1_S(365) RIPOR1_S(417) RIPOR1_S(5) RIPOR1_S(64) RIPOR1_S(707) RIPOR1_S(711) RIPOR1_S(723) RIPOR1_S(732) RIPOR1_S(748) RIPOR1_T(355) RIPOR1_T(728) RIPOR1_T(744) RIPOR1_Y(348)
RM2024_Intensity D4-1___3,,
RB2022_4_PostEndurance,,
FSO2013_Ratio M/L normalized Rep3,,
SR2019_MCF7_Biol_repl_3,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,
SR2019_LM2_Biol_repl_1,,
RCJD2014_15min_1,,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,
CK2022_7 16-1,,
NJH2025_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_C,0.5542844084547139,0.4273424797560191
RKK2015_TNF-α/basal,,
JJ2018_Ratio H/M normalized pP2,,
NJH2025_Sub12_MICT_Pre,,
NJH2025_Sub7_MICT_Post,,
DL2023_control-3,,
ZX2022_Control Replicate 2,0.564216065585738,0.43450491263048296
HS2024_6_B_T3,,
JW2015_Intensity pre1,,
IMM2018_normalised rep. int. Empty-3,,
AMK2021_30R_p5,,
FSO2013_Ratio M/L normalized Rep1,,
SR2019_MDAMB231_Biol_repl_4,,
GF2025_P2_Sph,0.562168393127801,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,
NJH2025_Sub13_HIIT_Mid,,
CP2009_Ratio M/L,,
NJH2025_Sub7_HIIT_Post,,
KBE2022_Log2_Ex_44_T,0.5409692401139111,
DB2022_Intensity L2,,
TM2022_mock.4h.C,,
AST2020_anti-CD3.2,,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,
HS2024_7_B_N1,,
FSO2013_Ratio M/L normalized Rep1___1,,
SAS2015_AZD/DMSO_Exp3,,
RM2024_Intensity D0-2___3,,
RM2024_Intensity D6-1,,
RB2022_8_RecoverySprint,,0.42978051938280126
RB2022_5_PreEndurance,0.5567859870374618,0.43336728055216006
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,
EP2017_Untreated R#4 normalized log2 ratio,0.5505340916048231,
WZ2023_Pu_010_30min,0.5795657262171948,0.42962037902638406
AS2011_Ratio H/L Proteins RNAi_2,,
RB2022_4_PreStrength,,
NJH2024_Sub4_MICT_Post,,
AH2018_LFQ_M_1_X,0.5606060973389043,0.4261905029758079
RB2022_8_RecoveryEndurance,,
KBE2022_Log2_Ex_14_U,0.5585808067586735,
FSO2013_Ratio M/L normalized Rep3___3,,
AH2018_TMTMS3_1_C,0.5646864884293705,0.43077300752328224
JJ2018_Ratio H/L normalized___1,,
ZQ2022_C2,,
RB2022_5_PreSprint,0.5585379138943267,0.4348169808965914
PG2020_Intensity 8h_C,,0.4318026203761748
AH2018_SILAC_MR_2_N,0.551599813258474,0.4259855162993891
MV2014_Ratio M/L normalized A1___2 (2 min),,
TM2022_S2.8h.B,,
MV2014_Ratio M/H normalized B3___1 (30 min),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,
RM2024_Intensity D6-1___2,,
NJH2025_Sub7_MICT_Mid,,
LY2019_P1+,0.5616663998859075,
AS2011_Ratio H/L Proteins Inhi_2,,
BS2014_Log2(Ratio H/L normalized),,
UK2020_HCM_2,0.5542925132974412,
FSO2013_Ratio H/L normalized Rep2___2,,
EP2017_Pervanadate R#3 normalized log2 ratio,0.5590844657171191,
RM2024_Intensity D4-3___3,,
RB2022_5_PreStrength,0.5576693398760828,
NJH2024_Sub4_MICT_Mid,,
TM2022_S2.4h.A,,
RB2022_5_PostStrength,0.5596404848356001,
GF2025_P6_Sph,0.5498839465730048,
RB2022_2_PreSprint,0.5578718578839232,
ZX2022_CB treated Replicate 3,0.5647406810754995,0.43259900822898373
RM2024_Intensity D6-2___3,,
WZ2023_Pe_025_10min,0.5799231064676016,0.4237242471817337
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,
AST2020_anti-CD3+PDL2.1,,
KBE2022_Log2_Ex_34_U,0.5465253584368182,
WZ2023_Pu_005_10min,0.5819318338371812,0.43490460984462626
AS2011_Ratio H/L RNAi_2_1,,
NJH2024_Sub9_HIIT_Mid,,
CK2022_9 40-1,,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,
LG2023_GSK3α-1_intensity,,
WZ2023_Pu_025_30min,0.5800374351985798,0.4372671513754114
AH2018_SILAC_MR_2_X,0.5521368851033043,0.4365018080720168
HS2024_4_PD_T2,,
NJH2024_Sub4_HIIT_Pre,,
RB2022_2_RecoverySprint,0.5633437375528783,
AS2011_Ratio H/L Protein RNAi_1,,
RM2024_Intensity D2-1___2,,
CR2017_Ratio Replicate 1.4,0.558096398754216,
FR2021_Norm.Intensity.B,,
RM2024_Intensity D6-2___1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,
RB2022_5_PostSprint,0.5609922615152066,0.4292288839584527
EJN2021_3_Rest_Basal,,0.42667766882061875
CR2017_Ratio Replicate 1.3,0.5700415941194844,0.4229136554698427
AS2011_Ratio H/L Normalized by Protein RNAi_2,,
KTGR2014_Ratio-Rapa 7 mins,,
AMK2021_120R_p1,,
AH2018_SILAC_3_X,0.5593173547648393,
JJ2018_Ratio M/L normalized pP3,,
AH2018_SILAC_M_2_N,0.5541553858859986,
HS2024_7_PD_T2,,
FSO2013_Ratio H/L normalized Rep1___1,,
AH2018_LFQ_1_C,0.5552915402251385,
AS2011_Ratio H/L Normalized Inhi_1_3,,
KBE2022_Log2_Ex_28_T,0.5588572370048095,
HS2024_3_B_N1,,
RM2024_Intensity D4-2___3,,
WZ2023_Pe_025_30min,0.5807488881034477,0.4258800395153789
CK2022_11 40-1,,
CW2012_10 µM Erl/control Experiment 3 Replicate B,,
AH2018_SILAC_2_X,0.5533501943167921,
MV2014_Ratio H/M normalized A2___2 (2 min),,
AS2011_Ratio H/L RNAi_1_2,,
KS2014_Intensity E15_1,0.5503582166824941,0.43115215563196985
FSO2013_Ratio H/L normalized Rep2,,
WZ2023_Pu_005_20min,0.5815584250411504,0.43842283604589166
NJH2024_Sub10_MICT_Post,,
RM2024_Intensity D2-3___1,,
CR2017_Ratio Replicate 1.5,0.561078907128193,
CW2012_10 µM Gef/control Experiment 2 Replicate B,,
HS2024_7_B_T3,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,
AS2011_Ratio H/L RNAi_1,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,
AH2018_LFQ_M_1_C,0.5578904784010502,0.42184482580062704
NJH2025_Sub7_MICT_Pre,,
SR2019_SKBR3_Biol_repl_2,,
HS2024_9_B_T2,,
KTGR2014_Ratio-AA 7 mins,,
MV2014_Ratio L/H normalized B3___3 (5 min),,
HS2024_3_PD_T1,,
FSO2013_Ratio M/L normalized Rep3___2,,
SR2019_BT549_Biol_repl_3,,
RCJD2014_20min_mean,,
FR2021_Norm.Intensity.H,,
RB2022_2_PreStrength,0.5562769231875323,
DB2022_LFQ intensity L1.2,,
HS2024_4_B_N1,,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,
CK2022_1 16-1,,
CK2022_1 200-1,0.5592608637502481,0.4316251392134632
PG2020_Intensity Mock_10h_D,0.5567624385574214,
SR2019_MCF10A_Biol_repl_2,,
JJ2018_Ratio M/L normalized pP2___2,,
HS2024_6_PD_T1,,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,
RB2022_6_RecoveryEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,
EP2017_Mitotic R#2 normalized log2 ratio,0.5636084956296258,
RCJD2014_5min_1,,
RM2024_Intensity D4-1___1,,
DL2023_24h-1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,
TM2022_S2.4h.C,,
SAS2015_PLX/AZD_Exp2,,
CR2017_Ratio Replicate 3.3,0.5620135690255014,0.42998776105659897
PG2020_Intensity 2h_C,0.5478988944582678,
VOI2024_Veh2 di,,
ZX2022_CB treated Replicate 2,0.5652093455741543,0.4322102041331519
KBE2022_Log2_Ex_8_T,0.5585639262755302,
NJH2025_Sub10_MICT_Post,,
HS2024_6_I_T3,,
RN2012_L11,0.56065534717497,
AS2011_Ratio H/L Normalized Inhi_2_2,,
IMM2018_normalised rep. int. Empty-1,,
HS2024_5_PD_T1,,
AH2018_LFQ_M_2_C,0.5506296642858903,
CK2022_3 40-1,,
RBK2021_1260T Early,,
NJH2024_Sub4_HIIT_Post,,
HS2024_4_I_T1,,
YA2020_Reporter_intensity_Cancer_No.5,0.5629525946515193,
HH2022_Reporter intensity 8,,
ZQ2022_N2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,
FSO2013_Ratio H/L normalized Rep3___3,,
AH2018_TMTMS3_2_N,0.5563929318621064,
EJN2021_5_Rest_Basal,,0.42868372142384265
NJH2025_Sub2_HIIT_Post,,
NJH2025_Sub1_MICT_Post,,
HS2024_9_B_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,
JAW2011_Ratio H/L LS2_1,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,
NJH2024_Sub6_HIIT_Pre,,
AH2018_SILAC_3_N,0.5593133055694948,
YA2020_Reporter_intensity_Normal_No.1,0.5646077698187066,
HS2024_3_B_T1,,
JJ2018_Ratio H/L normalized___2,,
RM2024_Intensity D0-2,,
MV2014_Ratio M/L normalized B1___2 (5 min),,
RB2022_7_PostStrength,,
RB2022_1_PostEndurance,0.5530972026918227,
CR2017_Ratio Replicate 3,0.5509834944591322,
SR2019_Hs578T_Biol_repl_3,,
MV2014_Ratio L/H normalized B3___1 (5 min),,
RBK2021_1244T Early,,
RB2022_3_PostSprint,,0.4295424792957049
NJH2024_Sub13_MICT_Mid,,
KTGR2014_Ratio-AA 2 mins,,
GF2025_P7_Sph,0.5587921832875593,
HS2024_8_I_T3,,
CF2017_EOC 3,0.5534838241830068,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,
HS2024_6_PD_T3,,
DL2023_12h-2,,
RM2024_Intensity D6-3___1,,
FS2019_Ctr1,,
WZ2023_Pu_010_20min,0.5798937882187961,0.4283718766300916
AS2011_Ratio H/L_3,,
CK2022_1 40-1,,
RNJ2017_Log2_ratio_Tsup:Trest_D1,,
CK2022_8 16-1,,
KS2014_Intensity N3,0.5661695700685064,0.4300076362961736
RB2022_4_RecoveryEndurance,,
RB2022_5_RecoveryEndurance,0.5604103931616929,0.43054451677010097
JAW2011_Ratio H/L LS1a_2,,
NJH2024_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_N,0.5552201970996994,0.42519306294128734
FSO2013_Ratio H/M normalized Rep2,,
RAM2015_Log2 A,,0.44452080752684237
HS2024_8_PD_T1,,
JJ2018_Ratio H/L normalized pP2,,
CF2017_OSE 27,0.56488861662671,0.43576595862822143
KS2014_Intensity E15_2,0.5507610639282275,0.43395539007607187
BS2014_Log2(Ratio H/L protein),,
PG2020_Intensity 8h_A,,0.4319940888434133
HS2024_7_I_T1,,
VOI2024_Veh3 di,,
RKK2015_TNF-α+SC-514/basal,,
SR2019_JIMT1_Biol_repl_1,,
HW2015_Ratio H/L normalized Exp2,,
HS2024_3_I_N1,,
AH2018_SILAC_M_3_X,0.5597544493108022,
NJH2024_Sub9_HIIT_Post,,
AS2011_Ratio H/L RNAi_1_3,,
GRW2016_Ratio H/L normalized SILAC 1___2,,
NJH2025_Sub1_HIIT_Pre,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,
NJH2024_Sub4_HIIT_Mid,,
VOI2024_0.1uM 2 h_1 di,,
KBE2022_Log2_Ex_6_T,0.5594162057839889,
RM2024_Intensity D4-3___1,,
AH2018_LFQ_4_X,0.5540781242577217,0.4266895246196203
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
RB2022_8_PostEndurance,,
NJH2025_Sub4_MICT_Mid,,
YP2020_Intensity C30_R1_mult_log2,,
AST2020_anti-CD3.1,,
NJH2025_Sub4_HIIT_Post,,
EP2017_Untreated R#4 log2 ratio,0.5517726643113042,
HS2024_6_B_N1,,
KBE2022_Log2_Ex_27_T,0.557651322820146,
CW2012_10 µM Gef/control Experiment 1 Replicate A,,
VOI2024_0.1uM 24 h_1 mono,,
AMK2021_120R_p5,,
AS2011_Ratio H/L Proteins,,
NJH2024_Sub7_HIIT_Post,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),0.5600106096406607,0.4270686144609446
AS2011_Ratio H/L RNAi_2_2,,
RB2022_7_RecoveryStrength,0.5615238018593045,
AH2018_SILAC_IT_3_X,0.5533716855649017,0.43589567627963766
JAW2011_Ratio H/L,,
PG2020_Intensity 10h_C,,0.4279827551952991
FSO2013_Ratio M/L normalized Rep2,,
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,
HH2022_Reporter intensity 5,,
SR2019_HCC1954_Biol_repl_2,,
CK2022_14 40-1,,
RB2022_6_PreSprint,,
NJH2025_Sub12_MICT_Mid,,
PG2020_Intensity 4h_D,0.5521606678618532,0.4155832897063637
NJH2025_Sub2_MICT_Post,,
AH2018_LFQ_4_C,0.5500751809333102,0.4267432713178017
DL2023_control-1,,
AR2021_ALG 10 μM,0.5749437221373442,0.4367670739092034
JAW2011_Ratio H/L LS2_2,,
AH2018_SILAC_IT_3_N,0.5518793814430614,0.43628693633316473
EJN2021_4_Rest_Ins,,0.4292062282892921
RN2012_H05,0.5531489697169748,
NJH2024_Sub7_HIIT_Mid,,
GF2025_P2_Adh,0.5669987516489166,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,
RB2022_8_PostSprint,,0.4361594241661411
EJN2021_1_Rest_Ins,,0.43230571978331017
HH2022_Reporter intensity 3,,0.4313352759488131
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,
AH2018_SILAC_IT_1_C,0.5534254433216308,0.4272588474849812
JW2021_After_3,,
GF2025_P8_Sph,0.5537953209291326,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,
JJ2018_Ratio M/L normalized pP2___1,,
AH2018_SILAC_2_N,0.5532410886084337,
CK2022_11 200-1,0.5591976924186983,0.429503226139958
CK2022_12 200-1,0.5598800150759347,0.4313404926576413
AS2011_Ratio H/L Normalized by Protein RNAi_1,,
RM2024_Intensity D2-1___3,,
NJH2024_Sub1_MICT_Pre,,
HH2022_Reporter intensity 9,,
WZ2023_Su_010_20min,0.5826046781950388,0.4415148426340941
AH2018_TMTMS2_2_N,0.5646913334023389,0.4316377859532022
NJH2024_Sub13_MICT_Pre,,
KBE2022_Log2_Ex_41_U,0.5448973924785399,
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),0.5604964263170291,0.43684321841707596
AH2018_TMTMS3_Pool,0.5545035230956327,
KS2014_Intensity N4,0.5614247180597672,0.43891650447433683
NJH2024_Sub1_HIIT_Post,,
MM2018_Ratio H/L replicate2,0.5602522858437768,
RM2024_Intensity D4-2___2,,
NJH2024_Sub13_HIIT_Pre,,
CF2017_OSE 26,0.5540113559671631,
CK2022_14 200-1,0.5589752591464295,0.43326615948260366
SR2019_Hs578T_Biol_repl_1,,
RB2022_7_PostSprint,0.5577478813065201,
TM2022_mock.4h.A,,
NJH2025_Sub12_HIIT_Pre,,
AH2018_TMTMS3_1_N,0.5580336847757772,
AST2020_anti-CD3+PDL2.2,,
PG2020_Intensity Mock_10h_A,0.5448867794757729,
JW2021_After_2,,
NJH2024_Sub2_MICT_Post,,
EJN2021_2_Rest_Ins,,0.4331126907086825
SR2019_LM2_Biol_repl_4,,
CP2009_Ratio H/M,,
JAW2011_Ratio H/L HS,,
CK2022_13 16-1,,
GF2025_P1_Adh,0.5725915169233267,
GF2025_P1_Sph,0.562090870629848,
EJN2021_5_Ex_Basal,,0.4299751601937296
HS2024_7_I_T3,,
JJ2018_Ratio H/L normalized pP2___2,,
WZ2023_Pe_010_10min,0.5801281125160125,0.42736126681970626
CF2017_EOC 1,,0.4324974671637001
CK2022_3 200-1,0.5593970525180597,0.43199566926826094
AH2018_LFQ_IT_3_C,0.5534299118396825,
SR2019_Hs578T_Biol_repl_2,,
NJH2024_Sub12_HIIT_Post,,
JJ2018_Ratio H/L normalized pP1___2,,
MV2014_Ratio H/L normalized A1___2 (10 min),,
NJH2024_Sub10_MICT_Mid,,
NJH2024_Sub13_MICT_Post,,
BS2014_Log2(Ratio H/L normalized Rep_1),,
RB2022_3_RecoverySprint,,0.42973988663293927
NJH2025_Sub1_HIIT_Mid,,
RCJD2014_20min_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,
HS2024_6_PD_T2,,
HS2024_5_B_T1,,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,
DL2023_12h-3,,
SR2019_MDAMB231_Biol_repl_2,,
HS2024_3_B_T2,,
RB2022_6_PreStrength,,
CK2022_2 40-1,,
RB2022_1_PostSprint,,
CK2022_4 200-1,0.558721437934121,0.43174533609262183
JW2021_Before_2,,
TM2022_S2.12h.A,,
MV2014_Ratio L/M normalized B2___2 (30 min),,
CK2022_5 16-1,,
AR2021_ALG 1 μM,0.5606412774551106,0.42435555375861095
HS2024_4_B_T1,,
MV2014_Ratio M/H normalized A3___1 (10 min),,
SR2019_BT549_Biol_repl_4,,
EJN2021_1_Rest_Basal,,0.4358734093683876
NJH2025_Sub8_MICT_Post,,
RCJD2014_5min_3,,
CR2017_Ratio Replicate 3.2,0.553452190484179,0.44027737514885235
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,
GF2025_P7_Adh,0.5644770073749354,
CK2022_9 16-1,,
NJH2024_Sub6_HIIT_Post,,
AMK2021_30R_p3,,
AS2011_Ratio H/L Normalized RNAi_2,,
RM2024_Intensity D0-2___2,,
KS2014_Intensity pY_N4,,
CK2022_13 200-1,0.5586134163615626,0.432666661388764
AS2011_Ratio H/L Normalized_2,,
PG2020_Intensity 6h_D,0.5496038690154524,0.427722249368051
CK2022_16 16-1,,
FS2019_db/db3,,
CK2022_15 40-1,,
NJH2024_Sub9_MICT_Pre,,
BS2014_Log2(Ratio H/L unmodified peptide),,
WZ2023_Su_005_10min,0.5812265094292173,0.4349770429355137
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,
KBE2022_Log2_Ex_41_T,0.5442859762059374,
AMK2021_Ctrl_p1,,
AH2018_LFQ_IT_3_X,0.5533516265422057,
HS2024_5_PD_T3,,
AH2018_TMTMS3_3_X,0.5567109986245609,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,
KBE2022_Log2_Ex_40_U,0.5604376112681064,
AH2018_LFQ_M_1_N,0.5572465348917458,0.42091003505189023
KBE2022_Log2_Ex_27_U,0.5583339083066076,
HW2015_Ratio M/L normalized Exp3,,
RKK2015_TNF-α/IKKb(K44M),,
AH2018_SILAC_M_1_N,0.5562502186007937,0.42590752391565484
HW2015_Ratio M/L normalized Exp1,,
RB2022_5_RecoveryStrength,0.5560944392118177,0.4278596027410776
YP2020_Intensity P10_R1_mult_log2,,
RB2022_7_PreStrength,0.5595049025696487,
YA2020_Reporter_intensity_Normal_No.4,0.5645931251248876,
NJH2025_Sub13_HIIT_Pre,,
PG2020_Intensity CT_D,0.5539169603221051,
NJH2025_Sub9_MICT_Post,,
VOI2024_Veh1 mono,,
CK2022_12 16-1,,
RN2012_L13,0.5553610634917201,
LG2023_Control-1_intensity,,
RM2024_Intensity D6-3___2,,
KBE2022_Log2_Ex_8_U,0.5571094862869082,
SR2019_SKBR3_Biol_repl_3,,
NJH2024_Sub1_MICT_Post,,
HS2024_3_I_T2,,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,
RM2024_Intensity D0-3___3,,
HS2024_6_I_T2,,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,
AS2011_Ratio H/L Protein Inhi_1,,
FSO2013_Ratio H/M normalized Rep2___1,,
GRW2016_Ratio M/L normalized SILAC 5a___2,,
CK2022_10 40-1,,
NJH2024_Sub12_HIIT_Pre,,
NJH2024_Sub8_MICT_Pre,,
RM2024_Intensity D0-1___1,,
LY2019_P3+,0.5608776819265041,
HH2022_Reporter intensity 6,,
RB2022_2_RecoveryStrength,0.5577609904280196,
KTGR2014_Ratio-AA 15 mins,,
AS2011_Ratio H/L Normalized RNAi_2_2,,
KS2014_Intensity pY_N3,,
MV2014_Ratio H/L normalized B1___2 (30 min),,
LY2019_P5-,0.5596097466200094,
HW2015_Ratio M/L normalized Exp2,,
SR2019_HCC1419_Biol_repl_1,,
AH2018_TMTMS2_3_X,0.5649687050251445,0.4316503839735501
GF2025_P3_Adh,0.5705855567864326,
SR2019_JIMT1_Biol_repl_2,,
AH2018_TMTMS2_1_C,0.5646346624142456,0.43085036501437185
RM2024_Intensity D0-1___2,,
LY2019_P4+,0.5555873073119724,
KBE2022_Log2_Ex_19_U,0.5605630522387369,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,
RB2022_4_PostStrength,,
LG2023_GSK3α-3_intensity,,
YA2020_Reporter_intensity_Cancer_No.1,0.5609017518205486,
AST2020_Control,,
JAW2011_Ratio H/L LS1a,,
RCJD2014_5min_mean,,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,
NJH2025_Sub1_MICT_Mid,,
TM2022_S2.12h.C,,
NJH2025_Sub9_MICT_Mid,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,
AS2011_Ratio H/L Normalized Inhi_1_2,,
FSO2013_Ratio M/L normalized Rep2___1,,
LG2023_Control-2_intensity,,
NJH2024_Sub8_HIIT_Pre,,
KS2014_Intensity pY_N2,,
RB2022_5_RecoverySprint,0.5643949750766762,
RB2022_7_RecoverySprint,0.561293230134368,
YA2020_Reporter_intensity_Normal_No.3,0.5651251887476446,
HS2024_8_B_T2,,
AH2018_LFQ_1_X,0.5594169859257753,
RM2024_Intensity D6-1___1,,
RCJD2014_10min_2,,
FR2021_Norm.Intensity.M,,
RM2024_Intensity D0-3___1,,
KS2014_Intensity N2,0.5673323993405941,0.4345522288256761
HH2022_Reporter intensity 1,,0.43124899653717835
HH2022_Reporter intensity 2,,0.4315010001514025
RM2024_Intensity D6-2___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,
RM2024_Intensity D2-3___2,,
YA2020_Reporter_intensity_Normal_No.5,0.5632080762538596,
SR2019_MCF7_Biol_repl_1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,
HS2024_8_B_T1,,
NJH2025_Sub6_HIIT_Pre,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,
EP2017_Untreated R#2 log2 ratio,0.5733008168947349,
SR2019_LM2_Biol_repl_3,,
RB2022_4_RecoveryStrength,,
CR2017_Ratio Replicate 2,0.5684731161597767,
CW2012_10 µM Erl/control Experiment 2 Replicate A,,
FSO2013_Ratio H/M normalized Rep3,,
AR2021_KD 72h,0.5556206545623038,0.4518711691634582
MV2014_Ratio H/M normalized B2___3 (5 min),,
KBE2022_Log2_Ex_18_U,0.5582250168350649,
AS2011_Ratio H/L Inhi_1_1,,
NJH2024_Sub8_MICT_Post,,
AH2018_TMTMS3_3_C,0.5551820173769558,
KBE2022_Log2_Ex_9_U,0.5612126275478462,
AH2018_SILAC_M_3_N,0.5597661507362636,
KBE2022_Log2_Ex_13_T,0.5595244338261731,
RM2024_Intensity D0-3,,
SR2019_SKBR3_Biol_repl_1,,
PG2020_Intensity Mock_10h_C,0.5563182896110952,
CF2017_OSE 29,0.561200094890481,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,
NJH2025_Sub1_HIIT_Post,,
DL2023_24h-2,,
HS2024_7_B_N2,,
PG2020_Intensity 10h_A,,0.4285401883092307
RN2012_L12,0.5643054822754052,
MV2014_Ratio M/L normalized B1___3 (5 min),,
NJH2024_Sub8_MICT_Mid,,
AH2018_LFQ_IT_4_C,0.5599891554297246,
SAS2015_PLX/AZD_Exp1,,
FR2021_Norm.Intensity.A,,
FSO2013_Ratio H/M normalized Rep1___1,,
JW2015_Intensity cap2,,
BS2014_Log2(Ratio H/L normalized Rep_2),,
NJH2024_Sub6_MICT_Post,,
CK2022_8 40-1,,
RB2022_7_RecoveryEndurance,0.5610660988801242,
NJH2025_Sub12_HIIT_Post,,
EJN2021_4_Ex_Basal,,0.4291902801772139
TM2022_S2.12h.B,,
RN2012_L15,0.5573104295739929,
KS2014_Intensity pY_PV3,,
TM2022_S2.4h.B,,
PG2020_Intensity 4h_A,0.5481142644654796,
FSO2013_Ratio H/M normalized Rep2___2,,
TM2022_mock.4h.B,,
KBE2022_Log2_Ex_24_U,0.5437079736407079,
NJH2025_Sub13_MICT_Mid,,
KS2014_Intensity C3,,0.4382077422537098
RB2022_1_PreSprint,0.5574036419635722,
HS2024_4_I_N1,,
CK2022_7 200-1,0.5609766128877788,0.43476473005737704
CK2022_5 200-1,0.561002720083008,0.435828312441613
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,
FSO2013_Ratio H/L normalized Rep2___1,,
NJH2024_Sub10_HIIT_Mid,,
RB2022_2_PostEndurance,,
AH2018_LFQ_2_C,0.5461364720497129,
AH2018_SILAC_MR_1_X,0.5498583675249162,0.4359856553119351
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,
IMM2018_normalised rep. int. Empty-2,,
RM2024_Intensity D4-1,,
KBE2022_Log2_Ex_25_U,0.543263503059727,
AH2018_SILAC_3_C,0.5599928430329407,
EJN2021_5_Rest_Ins,,0.43126716080395566
VOI2024_0.1uM 24 h_3 di,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,
DB2022_LFQ intensity L2.1,,
FSO2013_Ratio H/M normalized Rep1,,
CK2022_4 16-1,,
AS2011_Ratio H/L,,
SR2019_MCF7_Biol_repl_4,,
EJN2021_2_Ex_Ins,,0.4372744015935104
AS2011_Ratio H/L Inhi_2_3,,
JAW2011_Ratio H/L LS1a_1,,
AH2018_LFQ_1_N,0.5539216217409397,
SAS2015_PLX/DMSO_Exp1,,
SFR2015_HL_log2_ratio_avg_c,0.5525639966749213,
JJ2018_Ratio M/L normalized pP2,,
NJH2024_Sub7_MICT_Mid,,
PG2020_Intensity 6h_B,,0.43004173192303874
FSO2013_Ratio H/L normalized Rep3,,
GRW2016_Ratio H/L normalized SILAC 2___2,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,
JJ2018_Ratio M/L normalized,,
KTGR2014_Ratio-AA 30 mins,,
JW2021_After_1,,
NJH2025_Sub2_MICT_Mid,,
HS2024_6_B_N2,,
KBE2022_Log2_Ex_9_T,0.5585186477192567,
AH2018_SILAC_IT_2_N,0.5525315586703727,0.4362577880939586
AH2018_SILAC_IT_1_X,0.5534475971376795,0.43583865819833134
HW2015_Ratio H/L normalized Exp3,,
HS2024_7_PD_T1,,
UK2020_UA_2,0.5540090203759684,
RM2024_Intensity D2-1___1,,
GF2025_P10_Sph,0.5588300369607967,
WZ2023_Pe_025_20min,0.579135075610625,0.4337051601069527
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,
AH2018_LFQ_2_N,0.5496083422478516,0.42153489973264446
HS2024_4_I_N2,,
AH2018_TMTMS2_3_N,0.5648964787264992,0.43108825291321473
RN2012_H06,0.5656583458291917,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
HS2024_4_PD_T3,,
WZ2023_Su_005_30min,0.5820326599313831,0.439447575098173
SR2019_HCC1419_Biol_repl_4,,
JJ2018_Ratio H/M normalized___2,,
SR2019_JIMT1_Biol_repl_3,,
AS2011_Ratio H/L Protein,,
UK2020_HCM_3,0.5534794552131387,
NJH2024_Sub10_HIIT_Post,,
CR2017_Ratio Replicate 3.1,0.5535634493337007,
WZ2023_Su_025_10min,0.5830967627867676,0.43993090100611293
AH2018_LFQ_IT_4_X,0.5593167013350069,
CP2009_Ratio H/L,,
VOI2024_0.1uM 24 h_3 mono,,
RB2022_4_RecoverySprint,,
RM2024_Intensity D6-3,,
WZ2023_Su_005_20min,0.5815803164718837,0.4349753538931609
CW2012_10 µM Gef/control Experiment 1 Replicate B,,
SFR2015_HL_log2_ratio_avg_a,,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,
RB2022_1_PreEndurance,0.5594612542582325,0.4359200704778504
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,
LG2023_GSK3α-2_intensity,,
EP2017_Pervanadate R#1 log2 ratio,0.5636163406913803,
NJH2025_Sub6_HIIT_Post,,
RB2022_6_RecoverySprint,,
KS2014_Intensity,0.5650941537625767,0.4413377505863998
MV2014_Ratio H/M normalized A2___1 (2 min),,
PG2020_Intensity 8h_D,,0.4305391812769311
LY2019_P7+,0.5602064526579325,
EP2017_Untreated R#1 normalized log2 ratio,0.55317433712667,
RN2012_L10,,
PG2020_Intensity 4h_C,,0.4288946892136059
EP2017_Mitotic R#3 normalized log2 ratio,0.5540646072502466,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,
DB2022_LFQ intensity L1,,
KBE2022_Log2_Ex_24_T,0.5404653198198883,
RB2022_8_PostStrength,,
AH2018_SILAC_IT_2_X,0.5533150627865397,0.4358671501524557
HS2024_4_B_T3,,
NJH2024_Sub2_HIIT_Post,,
HS2024_8_B_N2,,
NJH2025_Sub8_HIIT_Pre,,
JJ2018_Ratio H/L normalized pP2___1,,
HS2024_8_I_T2,,
KBE2022_Log2_Ex_6_U,0.5586049814114113,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,
CR2017_Ratio Replicate 1.1,0.5645530179842773,
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,
MV2014_Ratio M/H normalized B3___2 (30 min),,
CK2022_16 200-1,0.5585332694211703,0.43331306529276903
VOI2024_0.1uM 2 h_3 di,,
EP2017_Mitotic R#1 normalized log2 ratio,0.569324288738852,
GF2025_P9_Sph,0.5521767261904732,
CK2022_6 200-1,0.5606907465436438,0.4329521352995261
NJH2024_Sub7_MICT_Post,,
AH2018_TMTMS3_2_X,0.5560637358355061,
NJH2024_Sub8_HIIT_Post,,
DB2022_LFQ intensity R1,,
JW2015_Intensity cap3,,
SR2019_HCC1954_Biol_repl_1,,
HS2024_4_I_T2,,
NJH2024_Sub2_MICT_Mid,,
VOI2024_0.1uM 2 h_2 mono,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,
HS2024_4_PD_T1,,
SAS2015_AZD/DMSO_Exp1,,
NJH2024_Sub1_MICT_Mid,,
IMM2018_normalised rep. int. CDK5L-3,,
HS2024_3_B_T3,,
MV2014_Ratio L/H normalized A3___2 (2 min),,
NJH2025_Sub13_MICT_Pre,,
SR2019_MDAMB231_Biol_repl_3,,
GRW2016_Ratio H/L normalized SILAC 4___1,,
MM2018_Ratio H/L replicate1,0.5568213649955938,
PG2020_Intensity 2h_D,0.5548922035097552,
EP2017_Untreated R#3 normalized log2 ratio,0.5566530423834818,
MV2014_Ratio M/H normalized A3___3 (10 min),,
NJH2024_Sub7_HIIT_Pre,,
JAW2011_Ratio H/L LS2,,
CK2022_8 200-1,0.5603608474799725,0.4347794948376434
KS2014_Intensity pY_C4,,
CR2017_Ratio Replicate 3.5,0.5624211049113672,
RB2022_7_PostEndurance,,
NJH2025_Sub4_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,
TM2022_mock.12h.A,,
JJ2018_Ratio H/L normalized pP1,,
EP2017_Pervanadate R#2 normalized log2 ratio,0.5709370704998411,
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,
KS2014_Intensity pY_E5_4,,
RM2024_Intensity D4-3___2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,
AH2018_SILAC_2_C,0.5534432846291409,
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
HS2024_7_I_N1,,
KBE2022_Log2_Ex_29_T,0.5587901152882353,
HS2024_7_I_T2,,
AS2011_Ratio H/L Normalized RNAi_2_3,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,
HS2024_6_B_T2,,
AMK2021_45I_p5,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,
SAS2015_PLX/DMSO_Exp2,,
EJN2021_1_Ex_Basal,,0.4374294460518084
FR2021_Intensity.M,,
RB2022_2_PostSprint,0.5595046757513626,
AH2018_SILAC_MR_3_N,0.5470425566753678,0.4367639908064673
MV2014_Ratio H/L normalized B1___3 (30 min),,
CF2017_FTE 13,0.5604152637051214,0.4355420533121827
PG2020_Intensity CT_C,0.5516271664549197,
ZCP2016_Ratio H/L Rep 1,,
FS2019_db/db2,,
KS2014_Intensity pY_PV4,,
KBE2022_Log2_Ex_39_U,0.5609609985362609,
EP2017_Untreated R#3 log2 ratio,0.5582624493642984,
RB2022_2_PostStrength,0.5610608695872558,
AS2011_Ratio H/L Normalized_1,,
MV2014_Ratio M/H normalized A3___2 (10 min),,
CR2017_Ratio Replicate 3.4,0.5560399293781505,
HS2024_8_PD_T2,,
FS2019_Ctr2,,
RB2022_6_PreEndurance,,
FR2021_Norm.Intensity.G,,
NJH2025_Sub9_HIIT_Post,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,
RM2024_Intensity D4-3,,
HS2024_8_B_N1,,
NJH2025_Sub10_MICT_Mid,,
KBE2022_Log2_Ex_15_U,0.5597459828300588,
AS2011_Ratio H/L Normalized Inhi_2,,
RKK2015_TNF-α/SC-514,,
RB2022_3_PreSprint,,0.4303983853632168
CR2017_Ratio Replicate 2.3,0.557516306223196,
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,
GF2025_P4_Adh,0.5597905987894088,
YA2020_Reporter_intensity_Normal_No.2,0.5651979630400117,
YP2020_Intensity P30_R2_mult_log2,,
NJH2025_Sub13_MICT_Post,,
HS2024_4_B_N2,,
HS2024_3_PD_T3,,
AMK2021_120R_p3,,
MV2014_Ratio L/H normalized A3___3 (2 min),,
NJH2025_Sub10_HIIT_Pre,,
FR2021_Intensity.G,,
RAM2015_Log2 C,0.5520465608841734,0.4302516587670463
AS2011_Ratio H/L Proteins Inhi_1,,
FSO2013_Ratio H/M normalized Rep1___3,,
AH2018_LFQ_M_2_N,0.554008995100346,0.42577169330759246
MV2014_Ratio M/L normalized A1___3 (2 min),,
KBE2022_Log2_Ex_40_T,0.5595026587936911,
CK2022_2 16-1,,
RAM2015_Log2 B,,0.45861019144746823
YP2020_Intensity C10_R1_mult_log2,,
FSO2013_Ratio M/L normalized Rep1___2,,
NJH2025_Sub8_MICT_Pre,,
EJN2021_4_Rest_Basal,,0.4256349618346481
YB2013_Ratio_H_L_Normalized_in_experiment_2,,
JJ2018_Ratio H/M normalized pP3___1,,
VOI2024_Veh2 mono,,
HS2024_6_B_T1,,
UK2020_HCM_5,0.554095498671858,
NJH2025_Sub10_HIIT_Post,,
VOI2024_0.1uM 2 h_3 mono,,
JW2015_Intensity pre3,,
AS2011_Ratio H/L Normalized Inhi_2_1,,
DL2023_24h-3,,
HS2024_7_PD_T3,,
PG2020_Intensity Mock_10h_B,,
WZ2023_Su_025_30min,0.5827720602280054,0.44037982981815477
AH2018_LFQ_4_N,0.5490899696017559,
CR2017_Ratio Replicate 1.2,0.5653014706172127,0.4274396878377494
AS2011_Ratio H/L Normalized by Proteins,,
RB2022_6_RecoveryStrength,,
HS2024_8_I_N1,,
AMK2021_Ctrl_p3,,
AS2011_Ratio H/L Protein Inhi_2,,
HH2022_Reporter intensity 7,,
AH2018_SILAC_M_1_X,0.5554954760700113,0.4282510864623323
RB2022_7_PreEndurance,0.5634452057132696,
VOI2024_0.1uM 24 h_2 di,,
DL2023_control-2,,
LY2019_P6+,0.556817860592044,
DB2022_LFQ intensity R2,,
GF2025_P6_Adh,0.5535094186181118,
VOI2024_Veh1 di,,
AS2011_Ratio H/L RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,
VOI2024_Veh3 mono,,
HS2024_5_I_T2,,
NJH2025_Sub7_HIIT_Mid,,
MV2014_Ratio H/L normalized B1___1 (30 min),,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,
RB2022_6_PostSprint,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,
AS2011_Ratio H/L Inhi_1,,
AS2011_Ratio H/L Normalized RNAi_1_2,,
AH2018_TMTMS3_2_C,0.5544988633273972,
SR2019_Hs578T_Biol_repl_4,,
RB2022_8_PreStrength,,
KS2014_Intensity C5,0.5534714438798274,0.4313025938132849
RM2024_Intensity D0-1,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,
YP2020_Intensity P30_R1_mult_log2,,
NJH2025_Sub2_HIIT_Pre,,
RB2022_3_RecoveryEndurance,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,
GF2025_P9_Adh,0.5555887322915145,
RB2022_3_PostStrength,,0.42699388629517027
TM2022_S2.8h.A,,
AS2011_Ratio H/L RNAi_1_1,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,
NJH2025_Sub2_MICT_Pre,,
MV2014_Ratio L/M normalized A2___3 (10 min),,
MV2014_Ratio H/M normalized A2___3 (2 min),,
HS2024_4_B_T2,,
SR2019_BT549_Biol_repl_1,,
AH2018_LFQ_M_4_N,0.5535194361448079,
NJH2024_Sub8_HIIT_Mid,,
PG2020_Intensity 8h_B,,0.43022975901546295
AH2018_LFQ_2_X,0.5519007507251633,
PG2020_Intensity 2h_B,0.5517081171551788,
AS2011_Ratio H/L Proteins RNAi_1,,
RB2022_4_PostSprint,,
KS2014_Intensity E15_3,,0.4315189213362628
GF2025_P3_Sph,0.5546412834224652,
DB2022_LFQ intensity L2,,
MV2014_Ratio H/L normalized A1___1 (10 min),,
AH2018_SILAC_1_C,0.5542970102872111,0.4273561797472246
NJH2024_Sub1_HIIT_Pre,,
FSO2013_Ratio M/L normalized Rep2___2,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),0.559093393651486,
AS2011_Ratio H/L RNAi_2_3,,
AH2018_SILAC_IT_1_N,0.5563551187692173,0.43626132451062566
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,
RB2022_4_PreEndurance,,
JJ2018_Ratio M/L normalized pP1,,
CR2017_Ratio Replicate 2.4,0.5615515092436789,
ZQ2022_N1,,
LY2019_P6-,0.55146033449095,
RM2024_Intensity D2-3,,
UK2020_HCM_1,0.553837206697896,
JW2015_Intensity pre2,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,
RM2024_Intensity D2-1,,
NJH2025_Sub12_MICT_Post,,
MV2014_Ratio H/M normalized B2___2 (5 min),,
RN2012_L14,0.561520426823509,
AH2018_LFQ_3_N,0.5462394456874167,
RKK2015_TNF-α/IKKb,,
SFR2015_HL_log2_ratio_std_b,0.5706943405484749,
UK2020_UA_1,0.5537509309815671,
KBE2022_Log2_Ex_13_U,0.5572311399920584,
AS2011_Ratio H/L Normalized Inhi_1,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,
RB2022_1_RecoverySprint,0.5645441148638948,0.43079041337978513
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,
JJ2018_Ratio H/L normalized pP3,,
CK2022_7 40-1,,
AS2011_Ratio H/L Inhi_1_3,,
NJH2025_Sub10_HIIT_Mid,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,
JAW2011_Ratio H/L LS1b_1,,
PG2020_Intensity 4h_B,,
SR2019_BT549_Biol_repl_2,,
RM2024_Intensity D4-2,,
DB2022_LFQ intensity R2.2,,
JJ2018_Ratio H/L normalized,,
RB2022_5_PostEndurance,,0.4289927580653617
HS2024_5_PD_T2,,
WZ2023_Su_025_20min,0.5823961423999057,0.43907651961502275
RM2024_Intensity D2-2___1,,
IMM2018_normalised rep. int. CDK5L-2,,
LY2019_P8-,0.5590991804729945,
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,
FSO2013_Ratio H/L normalized Rep1,,
NJH2024_Sub2_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,
CK2022_13 40-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,
RN2012_H02,,
PG2020_Intensity 10h_D,,0.43002135592923996
RB2022_8_PreEndurance,,0.4334430970330826
HS2024_3_B_N2,,
EJN2021_4_Ex_Ins,,0.42867418948139885
AS2011_Ratio H/L Normalized by Protein,,
EJN2021_1_Ex_Ins,,0.44085493425506
EP2017_Pervanadate R#3 log2 ratio,0.559084828220367,
FSO2013_Ratio M/L normalized Rep1___3,,
NJH2025_Sub4_HIIT_Mid,,
RCJD2014_5min_2,,
RB2022_6_PostStrength,,
AH2018_SILAC_MR_3_C,0.5514665316953954,0.4367922705955842
AH2018_LFQ_M_4_C,0.5556122308216602,0.42981926370786355
NJH2024_Sub4_MICT_Pre,,
AS2011_Ratio H/L Normalized Inhi_1_1,,
DL2023_12h-1,,
MV2014_Ratio L/M normalized B2___1 (30 min),,
DB2022_LFQ intensity L1.1,,
NJH2025_Sub6_MICT_Pre,,
NJH2025_Sub6_MICT_Post,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,
RN2012_H04,0.5634251315825858,
CK2022_6 40-1,,
DB2022_LFQ intensity R2.1,,
KBE2022_Log2_Ex_42_U,0.5592820739176287,
LY2019_P3-,0.5564590041777733,
FR2021_Intensity.A,,
EJN2021_3_Ex_Ins,,0.43646330547298196
MV2014_Ratio M/L normalized A1___1 (2 min),,
WZ2023_Pe_005_30min,0.5800924348699922,0.42996938367438153
HS2024_8_PD_T3,,
EJN2021_3_Ex_Basal,,0.4296403864341202
AST2020_Control.1,,
JW2015_Intensity cap1,,
PG2020_Intensity CT_A,,
FS2019_Ctr3,,
WZ2023_Pu_025_20min,0.5794513142820158,0.4328108615971595
NJH2025_Sub4_MICT_Post,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,
GF2025_P10_Adh,0.5578223066253887,
RB2022_1_RecoveryStrength,0.5594356309651964,0.43327318230311257
SR2019_HCC1954_Biol_repl_4,,
FR2021_Norm.Intensity.N,,
HS2024_5_B_N1,,
FSO2013_Ratio H/M normalized Rep3___3,,
AH2018_TMTMS2_2_C,0.5658347859577589,0.4315655896073625
RB2022_4_PreSprint,,
DB2022_Intensity R2,,
AH2018_TMTMS2_Pool,0.5558259354158072,
HS2024_8_I_N2,,
RB2022_3_RecoveryStrength,,0.43318144592288843
NJH2024_Sub6_HIIT_Mid,,
AH2018_SILAC_M_1_C,0.5562217269607986,0.4283459808350282
LY2019_P8+,0.558369721585237,
RB2022_2_RecoveryEndurance,0.5587991360381588,
JJ2018_Ratio H/M normalized pP2___1,,
JAW2011_Ratio H/L HS_1,,
RB2022_3_PostEndurance,,
KS2014_Intensity pY_PV1,,
JAW2011_Ratio H/L LS1b_2,,
SR2019_MCF7_Biol_repl_2,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),0.557658278561671,0.4306392211363588
AS2011_Ratio H/L Normalized RNAi_1_1,,
AH2018_LFQ_M_4_X,0.558128602423253,0.42972384660402174
NJH2024_Sub6_MICT_Pre,,
JJ2018_Ratio M/L normalized pP1___2,,
YP2020_Intensity C30_R2_mult_log2,,
NJH2024_Sub9_HIIT_Pre,,
AS2011_Ratio H/L Normalized Inhi_2_3,,
RM2024_Intensity D0-1___3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,
KBE2022_Log2_Ex_28_U,0.5599423881162896,
GRW2016_Ratio H/L normalized SILAC 1___1,,
CF2017_FTE 17,0.5585165449773795,0.42266979932872234
LY2019_P2-,0.5611712936361638,
AH2018_LFQ_IT_1_X,0.5544907022334347,0.42777171408849296
JJ2018_Ratio H/L normalized pP3___1,,
RB2022_8_RecoveryStrength,,0.42822996742036973
WZ2023_Pe_005_20min,0.5797990274277887,0.42670259379447
AST2020_Control.2,,
NJH2025_Sub6_MICT_Mid,,
RCJD2014_10min_1,,
FSO2013_Ratio H/L normalized Rep2___3,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,
HS2024_3_I_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,
CK2022_4 40-1,,
SR2019_MCF10A_Biol_repl_4,,
KS2014_Intensity pY_C5,,
NJH2025_Sub4_MICT_Pre,,
NJH2024_Sub9_MICT_Post,,
CF2017_OSE 28,0.5602235066556428,0.4309302897342957
HS2024_5_B_T2,,
HS2024_6_I_T1,,
HS2024_5_B_T3,,
JJ2018_Ratio H/M normalized pP1___1,,
KBE2022_Log2_Ex_36_U,0.5603206471215872,
AH2018_TMTMS3_3_N,0.5565213009313863,
SR2019_HCC1419_Biol_repl_2,,
FR2021_Intensity.N,,
AS2011_Ratio H/L Inhi_2_1,,
AH2018_SILAC_MR_1_C,0.5448960341953979,0.4362326114887065
NJH2024_Sub1_HIIT_Mid,,
NJH2025_Sub8_HIIT_Mid,,
EP2017_Mitotic R#3 log2 ratio,0.5532051215508054,
KBE2022_Log2_Ex_36_T,0.5600940214728813,
NJH2025_Sub6_HIIT_Mid,,
WZ2023_Pu_005_30min,0.5815961147935045,0.43408237972408403
KS2014_Intensity C2,0.5479143117518277,0.433322656514504
FSO2013_Ratio H/L normalized Rep1___2,,
RM2024_Intensity D2-2,,
KBE2022_Log2_Ex_42_T,0.5589300240114615,
CK2022_9 200-1,0.5594098262888416,0.4282394928517803
GRW2016_Ratio H/L normalized SILAC 2___1,,
JJ2018_Ratio H/M normalized pP3___2,,
DB2022_LFQ intensity R1.1,,
CK2022_10 200-1,0.5594914861185514,0.4280840938354353
NJH2024_Sub9_MICT_Mid,,
JAW2011_Ratio H/L_2,,
HS2024_7_I_N2,,
RBK2021_1332T Late,,
LY2019_P1-,0.5540906513750328,
RKK2015_TNF-α/basal.1,,
RKK2015_TNF-α/TNF-α+SC-514,,
CR2017_Ratio Replicate 2.5,0.5621580427658729,
HS2024_3_I_T3,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,
AS2011_Ratio H/L Normalized RNAi_1,,
KS2014_Intensity E15_4,0.5557397722056,0.429053562431109
ZQ2022_C3,,
EJN2021_3_Rest_Ins,,0.42587902882514195
YP2020_Intensity P10_R2_mult_log2,,
MV2014_Ratio H/L normalized A1___3 (10 min),,
NJH2025_Sub1_MICT_Pre,,
KBE2022_Log2_Ex_39_T,0.5604660406932043,
FSO2013_Ratio H/M normalized Rep3___2,,
RM2024_Intensity D6-2,,
EP2017_Untreated R#1 log2 ratio,0.5546593446251418,
RKK2015_SC-514/basal,,
RM2024_Intensity D6-1___3,,
WZ2023_Pu_010_10min,0.5796906948966564,0.43215400632717865
NJH2025_Sub9_HIIT_Mid,,
SR2019_SKBR3_Biol_repl_4,,
HS2024_5_I_T3,,
KS2014_Intensity N1,0.5660012565164321,0.44442876260986924
NJH2024_Sub12_MICT_Post,,
TM2022_S2.8h.C,,
CR2017_Ratio Replicate 1,0.5634366878683947,
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,
JJ2018_Ratio H/M normalized pP3,,
AH2018_SILAC_MR_2_C,0.5597305247825124,0.4361596994261121
LATM2013_Log2 Ratio (Medium/Light) Forward,,
PG2020_Intensity 2h_A,,
NJH2024_Sub6_MICT_Mid,,
NJH2025_Sub13_HIIT_Post,,
AH2018_SILAC_MR_3_X,0.5445671845596346,0.4365134676938724
JJ2018_Ratio H/M normalized___1,,
RCJD2014_15min_2,,
AS2011_Ratio H/L_2,,
AS2011_Ratio H/L Normalized,,
RN2012_H03,0.5666453692843247,
HS2024_5_B_N2,,
HS2024_5_I_N1,,
HS2024_6_I_N1,,
AR2021_KD 48h,0.5673325275225507,0.41323957846874976
FR2021_Intensity.B,,
RB2022_3_PreEndurance,,0.42613328493163805
HS2024_5_I_T1,,
NJH2024_Sub10_MICT_Pre,,
SR2019_LM2_Biol_repl_2,,
AST2020_anti-CD3,,
SR2019_MDAMB231_Biol_repl_1,,
RM2024_Intensity D2-3___3,,
WZ2023_Pe_005_10min,0.5804544162555041,0.4280909066275164
KBE2022_Log2_Ex_29_U,0.5598969980552109,
HS2024_7_B_T1,,
AH2018_LFQ_M_2_X,0.5462062078663522,
AH2018_LFQ_IT_4_N,0.5593206994354645,
CK2022_15 200-1,0.5581259675506393,0.43270037702774006
RM2024_Intensity D4-1___2,,
JJ2018_Ratio H/M normalized,,
JJ2018_Ratio M/L normalized pP3___1,,
KBE2022_Log2_Ex_34_T,0.5430430021238027,
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,
LY2019_P2+,0.5584674266404343,
LATM2013_Log2 Ratio (Light/Medium) Reverse,,
CK2022_2 200-1,0.559088744136006,0.4314262163764308
AS2011_Ratio H/L Protein RNAi_2,,
MV2014_Ratio L/H normalized A3___1 (2 min),,
WZ2023_Su_010_30min,0.5830301106755409,0.4403656214437094
RN2012_H01,,
KTGR2014_Ratio-Rapa 2 mins,,
EJN2021_2_Rest_Basal,,0.4301654703326038
KS2014_Intensity pY_E5_3,,
MM2018_Ratio H/L replicate 3,0.5586727211733693,
EP2017_Pervanadate R#1 normalized log2 ratio,0.5635022856303854,
HS2024_8_B_T3,,
YA2020_Reporter_intensity_Cancer_No.3,0.5611463996971473,
KBE2022_Log2_Ex_44_U,0.5431356403082325,
WZ2023_Pe_010_20min,0.5806001840090032,0.4321721225005039
KS2014_Intensity pY_C6,,
AS2011_Ratio H/L Normalized_3,,
RCJD2014_15min_mean,,
RB2022_3_PreStrength,,0.43282192351796656
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,
RCJD2014_10min_mean,,
KS2014_Intensity C1,,0.43620387503086194
FSO2013_Ratio H/M normalized Rep3___1,,
AH2018_SILAC_M_3_C,0.5603710481775716,
RKK2015_TNF-α+IKKb/TNF-α,,
RM2024_Intensity D0-3___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,
AH2018_SILAC_M_2_C,0.5540594387982585,
AH2018_SILAC_M_2_X,0.5533603999925686,
KTGR2014_Ratio-Rapa 15 mins,,
RM2024_Intensity D4-2___1,,
KBE2022_Log2_Ex_15_T,0.5591820063584688,
VOI2024_0.1uM 24 h_1 di,,
WZ2023_Su_010_10min,0.582582480477194,0.4399990993763108
PG2020_Intensity 6h_C,,0.4288438032851661
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,
JJ2018_Ratio M/L normalized pP1___1,,
AH2018_LFQ_M_3_N,0.5509993988178149,0.42484437492262733
VOI2024_0.1uM 24 h_2 mono,,
AH2018_TMTMS2_3_C,0.5653315284019707,0.43111724116488653
CK2022_15 16-1,,
CK2022_3 16-1,,
LY2019_P4-,0.5533118645945712,
FSO2013_Ratio H/L normalized Rep3___2,,
KS2014_Intensity pY_PV2,,
HS2024_3_I_N2,,
GF2025_P8_Adh,0.5543399267435325,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,
GF2025_P5_Sph,0.5689869308327766,
CK2022_10 16-1,,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,
VOI2024_0.1uM 2 h_2 di,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),0.5602462452102855,0.4310718401884152
NJH2024_Sub2_HIIT_Mid,,
AMK2021_45I_p3,,
NJH2024_Sub13_HIIT_Mid,,
DB2022_LFQ intensity R1.2,,
DB2022_Intensity R1,,
NJH2024_Sub12_MICT_Mid,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,
UK2020_HCM_4,0.5543800725781818,
SAS2015_AZD/DMSO_Exp2,,
IMM2018_normalised rep. int. CDK5L-1,,
DB2022_LFQ intensity L2.2,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,
EP2017_Mitotic R#1 log2 ratio,0.5665181978888914,
EJN2021_2_Ex_Basal,,0.42822209984786225
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,
KTGR2014_Ratio-Rapa 30 mins,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,
CF2017_FTE 16,0.5638880793947889,0.4359220448264968
AR2021_L41 10 μM,0.5518720828868047,0.4119439409081074
CF2017_EOC 2,0.5538352037398728,0.4292973282128772
RB2022_6_PostEndurance,,
AH2018_SILAC_1_N,0.5552229687114727,0.42519025039809
NJH2024_Sub10_HIIT_Pre,,
AS2011_Ratio H/L Inhi_1_2,,
UK2020_HCM_6,0.554279309756268,
RB2022_7_PreSprint,0.5587566838643185,
NJH2024_Sub2_MICT_Pre,,
HS2024_3_PD_T2,,
CK2022_6 16-1,,
ZX2022_CB treated Replicate 1,0.5644180243774846,0.4305483382385645
BS2014_Log2(Ratio H/L normalized Rep_3),,
TM2022_mock.12h.C,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,
HH2022_Reporter intensity 0,,0.4315376215654007
RM2024_Intensity D2-2___2,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,
RB2022_1_PreStrength,0.5582214577530807,
JJ2018_Ratio H/M normalized pP2___2,,
AH2018_TMTMS2_2_X,0.566024670220282,0.4313592707057855
AR2021_L41 1 μM,0.5540501092852981,0.40723205966535153
JJ2018_Ratio H/M normalized pP1___2,,
AH2018_TMTMS2_1_N,0.5646588743501617,0.43014363181931214
NJH2025_Sub10_MICT_Pre,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,
ZX2022_Control Replicate 3,0.5642562608958135,0.43037519775016975
KS2014_Intensity C4,0.5535052253539553,0.42922831050816146
AS2011_Ratio H/L Inhi_2,,
KBE2022_Log2_Ex_18_T,0.5601698385011368,
NJH2025_Sub9_MICT_Pre,,
RCJD2014_20min_1,,
MV2014_Ratio H/M normalized B2___1 (5 min),,
FSO2013_Ratio M/L normalized Rep2___3,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,
SR2019_MCF10A_Biol_repl_3,,
HS2024_7_B_T2,,
SAS2015_PLX/DMSO_Exp3,,
AMK2021_Ctrl_p5,,
NJH2025_Sub2_HIIT_Mid,,
AH2018_LFQ_M_3_C,0.5565827453218736,
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,
YA2020_Reporter_intensity_Cancer_No.2,0.5634999456811088,
FSO2013_Ratio H/M normalized Rep2___3,,
RB2022_8_PreSprint,,0.43516920987171553
AH2018_SILAC_IT_3_C,0.5533416908988602,0.42462773787894376
WZ2023_Pu_025_10min,0.5794062040543955,0.43068256004681393
RM2024_Intensity D2-2___3,,
AS2011_Ratio H/L_1,,
RCJD2014_10min_3,,
FSO2013_Ratio M/L normalized Rep3___1,,
SR2019_JIMT1_Biol_repl_4,,
YP2020_Intensity C10_R2_mult_log2,,
ZCP2016_Ratio H/L Rep 2,,
CF2017_EOC 4,0.561238510686805,0.426752463999234
JJ2018_Ratio H/L normalized pP1___1,,
WZ2023_Pe_010_30min,0.5798026604288201,0.42386887072934737
MV2014_Ratio L/M normalized B2___3 (30 min),,
AH2018_LFQ_IT_3_N,0.5532234568267362,
KS2014_Intensity C6,,0.43376162661470674
ZQ2022_N3,,
HW2015_Ratio H/L normalized Exp1,,
CK2022_12 40-1,,
NJH2024_Sub7_MICT_Pre,,
ZX2022_Control Replicate 1,0.5650543991536809,0.4350544631069444
JJ2018_Ratio H/M normalized pP1,,
CK2022_16 40-1,,
AH2018_SILAC_IT_2_C,0.5527278008837366,0.4270230268229388
CK2022_5 40-1,,
AH2018_LFQ_3_X,0.5549070188761354,
UK2020_UA_3,0.553384890733133,
LY2019_P7-,0.5509479397676269,
GF2025_P5_Adh,0.5703288316737828,
RB2022_1_PostStrength,0.559637902493327,
JAW2011_Ratio H/L LS1b,,
FSO2013_Ratio H/L normalized Rep3___1,,
SR2019_HCC1954_Biol_repl_3,,
CR2017_Ratio Replicate 2.2,0.5676276671130787,
VOI2024_0.1uM 2 h_1 mono,,
MV2014_Ratio L/M normalized A2___1 (10 min),,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,
CK2022_11 16-1,,
ZQ2022_C1,,
CR2017_Ratio Replicate 2.1,0.5594456063519392,
PG2020_Intensity CT_B,0.5542474679156427,
JJ2018_Ratio M/L normalized___2,,
AH2018_SILAC_MR_1_N,0.5510136086516788,0.4260664572848789
KS2014_Intensity pY_E5_1,,
JW2021_Before_3,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,
MV2014_Ratio M/H normalized B3___3 (30 min),,
FS2019_db/db1,0.5492394761629831,
NJH2025_Sub9_HIIT_Pre,,
JAW2011_Ratio H/L_1,,
RCJD2014_20min_3,,
AH2018_LFQ_3_C,0.5527443444633715,
JJ2018_Ratio M/L normalized pP3___2,,
AMK2021_45I_p1,,
NJH2025_Sub8_HIIT_Post,,
AH2018_LFQ_M_3_X,0.5582085385566514,0.42587627270681305
YA2020_Reporter_intensity_Cancer_No.4,0.5621975213910897,
KS2014_Intensity pY_E5_2,,
FSO2013_Ratio H/L normalized Rep1___3,,
GF2025_P4_Sph,0.5586327124399644,
RB2022_2_PreEndurance,0.5624830882594979,
JW2021_Before_1,,
KBE2022_Log2_Ex_25_T,0.5405263396022109,
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,
MV2014_Ratio L/M normalized A2___2 (10 min),,
JJ2018_Ratio M/L normalized___1,,
FR2021_Intensity.H,,
CK2022_14 16-1,,
AST2020_anti-CD3+PDL2,,
MV2014_Ratio M/L normalized B1___1 (5 min),,
KBE2022_Log2_Ex_19_T,0.558443116077967,
KS2014_Intensity pY_N1,,
RB2022_1_RecoveryEndurance,0.5577646283488474,0.4345387191372433
FSO2013_Ratio H/M normalized Rep1___2,,
HS2024_8_I_T1,,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,
EP2017_Mitotic R#2 log2 ratio,0.560960685349348,
AH2018_TMTMS2_1_X,0.564798350165454,0.4303165190387453
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,
ZCP2016_Ratio H/L Rep 3,,
AS2011_Ratio H/L Normalized RNAi_1_3,,
SR2019_MCF10A_Biol_repl_1,,
NJH2025_Sub8_MICT_Mid,,
EJN2021_5_Ex_Ins,,0.43544368565725383
HS2024_6_I_N2,,
HH2022_Reporter intensity 4,,
RBK2021_1326T Late,,
TM2022_mock.12h.B,,
NJH2024_Sub12_MICT_Pre,,
RCJD2014_15min_3,,
MV2014_Ratio L/H normalized B3___2 (5 min),,
LG2023_Control-3_intensity,,
JJ2018_Ratio H/L normalized pP3___2,,
CF2017_FTE 15,0.5623668294658176,0.43327410675055755
HS2024_4_I_T3,,
AH2018_SILAC_1_X,0.5544854426169434,0.4277731656232806
PG2020_Intensity 10h_B,,0.4288716406268661
AH2018_TMTMS3_1_X,0.5565335934703202,
CF2017_FTE 14,0.5599440578219291,
NJH2024_Sub13_HIIT_Post,,
RM2024_Intensity D6-3___3,,
NJH2025_Sub7_HIIT_Pre,,
RBK2021_1259T Early,,
RKK2015_IKK+TNF-α/IKKb,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,
PG2020_Intensity 6h_A,0.5506101343336329,0.42822712330359947
SR2019_HCC1419_Biol_repl_3,,
KBE2022_Log2_Ex_14_T,0.5588823147503474,
EP2017_Untreated R#2 normalized log2 ratio,0.5716892800971929,
RM2024_Intensity D0-2___1,,
DB2022_Intensity L1,,
LY2019_P5+,0.5584378500450924,
HS2024_5_I_N2,,
SAS2015_PLX/AZD_Exp3,,
EP2017_Pervanadate R#2 log2 ratio,0.570965543822006,
AS2011_Ratio H/L Normalized RNAi_2_1,,
